AAAAAA

   
Results: 1-19 |
Results: 19
EFFICACY AND SAFETY OF NEUROLEPTICS IN BEHAVIORAL-DISORDERS ASSOCIATED WITH DEMENTIA
Authors: LANCTOT KL BEST TS MITTMANN N LIU BA OH PI EINARSON TR NARANJO CA
Citation: Kl. Lanctot et al., EFFICACY AND SAFETY OF NEUROLEPTICS IN BEHAVIORAL-DISORDERS ASSOCIATED WITH DEMENTIA, The Journal of clinical psychiatry, 59(10), 1998, pp. 550-561
QUANTIFYING THE COSTS OF SERIOUS ADVERSE DRUG-REACTIONS TO ANTIEPILEPTIC DRUGS
Authors: SCHLIENGER RG OH PI KNOWLES SR SHEAR NH
Citation: Rg. Schlienger et al., QUANTIFYING THE COSTS OF SERIOUS ADVERSE DRUG-REACTIONS TO ANTIEPILEPTIC DRUGS, Epilepsia, 39, 1998, pp. 27-32
COGNITIVE ENHANCERS IN ALZHEIMERS-DISEASE - WORTHWHILE
Authors: LANCTOT KL RISEBROUGH N OH PI
Citation: Kl. Lanctot et al., COGNITIVE ENHANCERS IN ALZHEIMERS-DISEASE - WORTHWHILE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 92-92
MULTINATIONAL PHARMACOECONOMIC ANALYSIS OF TOPICAL AND ORAL THERAPIESFOR ONYCHOMYCOSIS
Authors: EINARSON TR OH PI GUPTA AK SHEAR NH
Citation: Tr. Einarson et al., MULTINATIONAL PHARMACOECONOMIC ANALYSIS OF TOPICAL AND ORAL THERAPIESFOR ONYCHOMYCOSIS, Journal of dermatological treatment, 8(4), 1997, pp. 229-235
ECONOMIC APPRAISAL OF PHARMACOLOGICAL THERAPY FOR BEHAVIORAL-DISORDERS IN DEMENTIA
Authors: LANCTOT KL OH PI HERRMANN N LIU BA
Citation: Kl. Lanctot et al., ECONOMIC APPRAISAL OF PHARMACOLOGICAL THERAPY FOR BEHAVIORAL-DISORDERS IN DEMENTIA, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 34-34
THROMBOLYTIC THERAPY IN ACUTE STROKE - IS IT WORTH THE PRICE
Authors: OH PI PRITCHARDOH L
Citation: Pi. Oh et L. Pritchardoh, THROMBOLYTIC THERAPY IN ACUTE STROKE - IS IT WORTH THE PRICE, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 78-78
OVERTREATMENT OF HYPERTENSION IN THE COMMUNITY
Authors: MYERS MG REEVES RA OH PI JOYNER CD
Citation: Mg. Myers et al., OVERTREATMENT OF HYPERTENSION IN THE COMMUNITY, American journal of hypertension, 9(5), 1996, pp. 419-425
A COST-UTILITY ANALYSIS OF 2ND-LINE ANTIBIOTICS IN THE TREATMENT OF ACUTE OTITIS-MEDIA IN CHILDREN
Authors: OH PI MAEROV P PRITCHARD D KNOWLES SR EINARSON TR SHEAR NH
Citation: Pi. Oh et al., A COST-UTILITY ANALYSIS OF 2ND-LINE ANTIBIOTICS IN THE TREATMENT OF ACUTE OTITIS-MEDIA IN CHILDREN, Clinical therapeutics, 18(1), 1996, pp. 160-182
ECONOMIC-EVALUATION OF ACARBOSE IN THE TREATMENT OF NON-INSULIN-DEPENDENT DIABETES (NIDDM)
Authors: MACKEIGAN LD OH PI
Citation: Ld. Mackeigan et Pi. Oh, ECONOMIC-EVALUATION OF ACARBOSE IN THE TREATMENT OF NON-INSULIN-DEPENDENT DIABETES (NIDDM), Diabetes, 45, 1996, pp. 271-271
COST-UTILITY ANALYSIS (CUA) OF 2ND LINE ANTIBIOTICS IN THE TREATMENT OF ACUTE OTITIS-MEDIA
Authors: OH PI MAEROV P PRITCHARD D KNOWLES SR EINARSON TR SHEAR NH
Citation: Pi. Oh et al., COST-UTILITY ANALYSIS (CUA) OF 2ND LINE ANTIBIOTICS IN THE TREATMENT OF ACUTE OTITIS-MEDIA, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 87-87
PREVALENCE OF WHITE COAT EFFECT IN TREATED HYPERTENSIVE PATIENTS IN THE COMMUNITY
Authors: MYERS MG OH PI REEVES RA JOYNER CD
Citation: Mg. Myers et al., PREVALENCE OF WHITE COAT EFFECT IN TREATED HYPERTENSIVE PATIENTS IN THE COMMUNITY, American journal of hypertension, 8(6), 1995, pp. 591-597
POSSIBLE OVERTREATMENT OF HYPERTENSION IN THE COMMUNITY
Authors: MYERS MG OH PI REEVES RA JOYNER CD
Citation: Mg. Myers et al., POSSIBLE OVERTREATMENT OF HYPERTENSION IN THE COMMUNITY, Hypertension, 25(6), 1995, pp. 1355-1355
FELODIPINE COMPLIANCE, BLOOD-PRESSURE (BP) CONTROL AND PHARMACOKINETICS (PK) IN HYPERTENSIVE CHILDREN
Authors: BLOWEY DL MONCICA I OH PI SCOLNIK D ARBUS GS HEBERT D BALFE JW KOREN G
Citation: Dl. Blowey et al., FELODIPINE COMPLIANCE, BLOOD-PRESSURE (BP) CONTROL AND PHARMACOKINETICS (PK) IN HYPERTENSIVE CHILDREN, Pediatric research, 37(4), 1995, pp. 359-359
ANTICOAGULANT-THERAPY IN THE COMMUNITY EFFICACY VERSUS EFFECTIVENESS
Authors: OH PI MYERS MG
Citation: Pi. Oh et Mg. Myers, ANTICOAGULANT-THERAPY IN THE COMMUNITY EFFICACY VERSUS EFFECTIVENESS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 147-147
EFFICACY AND SAFETY OF NEUROLEPTICS IN BEHAVIORAL-DISORDERS ASSOCIATED WITH DEMENTIA
Authors: LANCTOT KL MITTMANN N LIU B BEST T OH PI EINARSON TR NARANJO CA
Citation: Kl. Lanctot et al., EFFICACY AND SAFETY OF NEUROLEPTICS IN BEHAVIORAL-DISORDERS ASSOCIATED WITH DEMENTIA, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 199-199
BENZODIAZEPINES AND FALLS IN THE ELDERLY - A METAANALYSIS
Authors: LIU BA MITTMANN N LANCTOT KL OH PI EINARSON TR SHEAR NH
Citation: Ba. Liu et al., BENZODIAZEPINES AND FALLS IN THE ELDERLY - A METAANALYSIS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 200-200
A CROSSOVER COMPARISON OF EXTENDED-RELEASE FELODIPINE WITH PROLONGED ACTION NIFEDIPINE IN HYPERTENSION
Authors: MONCICA I OH PI QAMAR IU SCOLNIK D ARBUS GS HEBERT D BALFE JW KOREN G
Citation: I. Moncica et al., A CROSSOVER COMPARISON OF EXTENDED-RELEASE FELODIPINE WITH PROLONGED ACTION NIFEDIPINE IN HYPERTENSION, Archives of Disease in Childhood, 73(2), 1995, pp. 154-156
A COMPARISON OF METHODS FOR THE ASSESSMENT OF SUSPECTED ADVERSE DRUG REACTION IN THE CLINIC SETTING
Authors: OH PI KWOK M SHEAR NH LANCTOT KL KNOWLES S NARANJO CA
Citation: Pi. Oh et al., A COMPARISON OF METHODS FOR THE ASSESSMENT OF SUSPECTED ADVERSE DRUG REACTION IN THE CLINIC SETTING, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 156-156
WHITE COAT HYPERTENSION IN THE PRIMARY-CARE SETTING
Authors: OH PI MYERS MG REEVES RA
Citation: Pi. Oh et al., WHITE COAT HYPERTENSION IN THE PRIMARY-CARE SETTING, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 206-206
Risultati: 1-19 |